General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.
The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, P.R. China.
Oncol Rep. 2022 May;47(5). doi: 10.3892/or.2022.8307. Epub 2022 Mar 24.
MicroRNAs (miRNAs/miRs), non‑coding single‑stranded RNAs of length 18‑24 nucleotides, can modulate gene expression through post‑transcriptional control. As such, they can influence tumor proliferation, apoptosis, invasion, metastasis as well as chemotherapy resistance by regulating certain downstream genes. In this context, miR‑200b‑3p, one particular member of the miR‑200 family, possesses the ability to suppress tumor progression. However, many studies have suggested that, in certain cases, this miRNA may also promote the development of some tumors due to differences in the microenvironments and molecular backgrounds of different cancers. This review summarizes previous studies on the involvement of miR‑200b‑3p in tumors, including the underlying mechanism.
微小 RNA(miRNA/miRs)是一种长度为 18-24 个核苷酸的非编码单链 RNA,可通过转录后调控来调节基因表达。因此,通过调节某些下游基因,它们可以影响肿瘤的增殖、凋亡、侵袭、转移以及化疗耐药性。在这种情况下,miR-200b-3p 是 miR-200 家族的一个特定成员,具有抑制肿瘤进展的能力。然而,许多研究表明,由于不同癌症的微环境和分子背景的差异,在某些情况下,这种 miRNA 也可能促进某些肿瘤的发展。本综述总结了 miR-200b-3p 参与肿瘤的相关研究,包括其潜在机制。